An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Sponsor: GVK Biosciences
This NA trial investigates Visceral Leishmaniasis and is currently completed. GVK Biosciences leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Dec 2019 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GVK Biosciences
- International Centre for Diarrhoeal Disease Research, Bangladesh
- PATH
- Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bhaluka, Bangladesh
- • Dhaka, Bangladesh
- • Trishal, Bangladesh